 associ bullou pemphigoid malign diseas case control studi case control studi incid malign diseas patient bullou pemphigoid BP control rate malign diseas past concurr follow-up BP patient control number malign BP group doubt signific remot attribut treatment rate concurr BP malign week slight excess malign BP insuffici extens investig pursuit cancer comparison BP patient cancer clinic immunopatholog subgroup investig patient BP malign hla-dr posit immunogenet predisposit diseas